Ming Kai Lam

623 total citations
24 papers, 438 citations indexed

About

Ming Kai Lam is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ming Kai Lam has authored 24 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 14 papers in Cardiology and Cardiovascular Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ming Kai Lam's work include Coronary Interventions and Diagnostics (21 papers), Cardiac Valve Diseases and Treatments (11 papers) and Cardiac Imaging and Diagnostics (9 papers). Ming Kai Lam is often cited by papers focused on Coronary Interventions and Diagnostics (21 papers), Cardiac Valve Diseases and Treatments (11 papers) and Cardiac Imaging and Diagnostics (9 papers). Ming Kai Lam collaborates with scholars based in Netherlands, Greece and Belgium. Ming Kai Lam's co-authors include Clemens von Birgelen, Gerard C.M. Linssen, Marije M. Löwik, Hanim Sen, Kenneth Tandjung, Frits H.A.F. de Man, Carine J.M. Doggen, Martin G. Stoel, J. W. Louwerenburg and K. Gert van Houwelingen and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and American Heart Journal.

In The Last Decade

Ming Kai Lam

24 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming Kai Lam Netherlands	10	375	302	165	134	10	24	438
Jack Hall United States	9	282 0.8×	235 0.8×	118 0.7×	90 0.7×	6 0.6×	17	379
Paolo Zocca Netherlands	14	584 1.6×	521 1.7×	96 0.6×	144 1.1×	7 0.7×	37	673
Alberto Benassi Italy	12	349 0.9×	366 1.2×	97 0.6×	146 1.1×	7 0.7×	20	473
Girish Mood United States	6	435 1.2×	359 1.2×	103 0.6×	108 0.8×	10 1.0×	8	502
A. Kastrati Germany	4	326 0.9×	358 1.2×	70 0.4×	84 0.6×	15 1.5×	6	437
J. W. Louwerenburg Netherlands	12	681 1.8×	583 1.9×	211 1.3×	185 1.4×	4 0.4×	23	762
Thaddeus R. Tolleson United States	8	410 1.1×	432 1.4×	108 0.7×	128 1.0×	4 0.4×	14	543
Gaetano Di Palma Italy	12	389 1.0×	259 0.9×	169 1.0×	146 1.1×	9 0.9×	31	474
Hans Störger Germany	11	428 1.1×	305 1.0×	217 1.3×	152 1.1×	5 0.5×	36	511
Hans-Peter Stoll Netherlands	6	525 1.4×	446 1.5×	305 1.8×	157 1.2×	19 1.9×	7	637

Countries citing papers authored by Ming Kai Lam

Since Specialization

Citations

This map shows the geographic impact of Ming Kai Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Kai Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Kai Lam more than expected).

Fields of papers citing papers by Ming Kai Lam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Kai Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Kai Lam. The network helps show where Ming Kai Lam may publish in the future.

Co-authorship network of co-authors of Ming Kai Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Kai Lam. A scholar is included among the top collaborators of Ming Kai Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Kai Lam. Ming Kai Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tandjung, Kenneth, Ming Kai Lam, Hanim Sen, et al.. (2016). Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial. EuroIntervention. 12(4). 431–440. 5 indexed citations

Kok, Marlies M., Clemens von Birgelen, Ming Kai Lam, et al.. (2016). Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study. EuroIntervention. 11(13). 1487–1494. 3 indexed citations

Houwelingen, K. Gert van, Ming Kai Lam, Marije M. Löwik, et al.. (2016). Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From the DUTCH PEERS (TWENTE II) Randomized Trial. Revista Española de Cardiología (English Edition). 69(12). 1152–1159. 5 indexed citations

Houwelingen, K. Gert van, Ming Kai Lam, Marije M. Löwik, et al.. (2016). Resultados de los stents Resolute Integrity y Promus Element en el infarto de miocardio: análisis del ensayo aleatorizado DUTCH PEERS (TWENTE II ). Revista Española de Cardiología. 69(12). 1152–1159. 5 indexed citations

Houwelingen, K. Gert van, Liefke C. van der Heijden, Ming Kai Lam, et al.. (2016). Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial. Heart and Vessels. 31(11). 1731–1739. 7 indexed citations

Tu, Shengxian, Mauro Echavarría‐Pinto, Clemens von Birgelen, et al.. (2015). Fractional Flow Reserve and Coronary Bifurcation Anatomy. JACC: Cardiovascular Interventions. 8(4). 564–574. 61 indexed citations

Sen, Hanim, Ming Kai Lam, Marije M. Löwik, et al.. (2015). Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents. JACC: Cardiovascular Interventions. 8(7). 889–899. 34 indexed citations

Heijden, Liefke C. van der, Marlies M. Kok, Ming Kai Lam, et al.. (2015). Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial. Clinical Research in Cardiology. 105(3). 206–215. 9 indexed citations

Lam, Ming Kai, Kenneth Tandjung, Hanim Sen, et al.. (2015). Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial. EuroIntervention. 11(2). 180–187. 14 indexed citations

10.

Löwik, Marije M., Ming Kai Lam, Hanim Sen, et al.. (2015). Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial. EuroIntervention. 10(11). 1276–1279. 12 indexed citations

11.

Birgelen, Clemens von, Ming Kai Lam, Liefke C. van der Heijden, et al.. (2014). TCT-588 2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromium Everolimus-Eluting Promus Element Stents in “All-Comer” Patients. Journal of the American College of Cardiology. 64(11). B171–B171. 1 indexed citations

12.

Sen, Hanim, Ming Kai Lam, Kenneth Tandjung, et al.. (2014). Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry. International Journal of Cardiology. 176(3). 885–890. 8 indexed citations

13.

Lam, Ming Kai, Hanim Sen, K. Gert van Houwelingen, et al.. (2014). Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial. American Heart Journal. 169(1). 69–77. 15 indexed citations

14.

Sen, Hanim, Ming Kai Lam, Kenneth Tandjung, et al.. (2014). Complex patients treated with zotarolimus‐eluting resolute and everolimus‐eluting xience V stents in the randomized TWENTE trial: Comparison of 2‐year clinical outcome. Catheterization and Cardiovascular Interventions. 85(1). 74–81. 7 indexed citations

15.

Lam, Ming Kai, Hanim Sen, Kenneth Tandjung, et al.. (2014). Clinical outcome of patients with implantation of second‐generation drug‐eluting stents in the right coronary ostium: Insights from 2‐year follow‐up of the TWENTE trial. Catheterization and Cardiovascular Interventions. 85(4). 524–531. 10 indexed citations

16.

Lam, Ming Kai, Hanim Sen, Kenneth Tandjung, et al.. (2014). Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): Rationale and study design of the randomized TWENTE III multicenter trial. American Heart Journal. 167(4). 445–451. 21 indexed citations

17.

Tandjung, Kenneth, Hanim Sen, Ming Kai Lam, et al.. (2013). Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents. Journal of the American College of Cardiology. 61(24). 2406–2416. 56 indexed citations

18.

Birgelen, Clemens von, Hanim Sen, Ming Kai Lam, et al.. (2013). Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial. The Lancet. 383(9915). 413–423. 140 indexed citations

19.

Lam, Ming Kai, Gooitzen M. van Dam, René A. Tio, et al.. (2012). Single-Chain VEGF/Cy5.5 Targeting VEGF Receptors to Indicate Atherosclerotic Plaque Instability. Molecular Imaging and Biology. 15(3). 250–261. 10 indexed citations

20.

Lam, Ming Kai & Leo Hofstra. (2010). The electrocardiogram of a man found in the forest.. PubMed. 68(11). 372, 376–372, 376. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact